Reapplix Overview
- Year Founded
-
2008

- Status
-
Private
- Employees
-
31

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$22.6M
- Investors
-
10
Reapplix General Information
Description
Manufacturer of a tissue regeneration device designed to offer biological treatment and management of diabetic foot ulcers. The company offers evidence-based biological wound therapy made entirely from the patient's blood to accelerate the healing of hard-to-heal diabetic foot ulcers, enabling hospitals to provide autologous active cell therapy to their patients to improve healing outcomes while reducing treatment costs.
Contact Information
Website
www.reapplix.comCorporate Office
- Bregnerødvej 133A
- 3460 Birkerod
- Denmark
Corporate Office
- Bregnerødvej 133A
- 3460 Birkerod
- Denmark
Reapplix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 13-Jul-2020 | $22.6M | Completed | Generating Revenue | ||
6. Later Stage VC | 23-Oct-2019 | Completed | Generating Revenue | |||
5. Later Stage VC | 31-Dec-2018 | Completed | Generating Revenue | |||
4. Later Stage VC | 27-Sep-2016 | Completed | Generating Revenue | |||
3. Early Stage VC | 21-Dec-2012 | Completed | Generating Revenue | |||
2. Early Stage VC | 02-Sep-2010 | $2M | $2.51M | Completed | Generating Revenue | |
1. Seed Round | 01-Mar-2010 | $508K | $508K | Completed | Startup |
Reapplix Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
D shares | ||||||||
C shares | 145,000 | $12.08 | $12.08 | 1x | $12.08 | 2.7% | ||
B shares | 98,930 | $4.23 | $4.23 | 1x | $4.23 | 1.84% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Reapplix Comparisons
Industry
Financing
Details
Reapplix Competitors (6)
One of Reapplix’s 6 competitors is NOVADIP, a Venture Capital-Backed company based in Mont-Saint-Guibert, Belgium.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NOVADIP | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | ||||
Podimetrics | Venture Capital-Backed | Somerville, MA | ||||
Amnio Technology | Accelerator/Incubator Backed | Phoenix, AZ | ||||
Mölnlycke Health Care | Private Equity-Backed | Mölndal, Sweden | ||||
Globus Medical | Formerly VC-backed | Audubon, PA |
Reapplix Signals
Reapplix Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Angel (individual) | Minority | |||
Angel (individual) | Minority | |||
Lauxera Capital Partners | Growth/Expansion | Minority | ||
MK Ventures | Venture Capital | Minority | ||
North East Health Care | Corporation | Minority |
Reapplix FAQs
-
When was Reapplix founded?
Reapplix was founded in 2008.
-
Where is Reapplix headquartered?
Reapplix is headquartered in Birkerod, Denmark.
-
What is the size of Reapplix?
Reapplix has 31 total employees.
-
What industry is Reapplix in?
Reapplix’s primary industry is Therapeutic Devices.
-
Is Reapplix a private or public company?
Reapplix is a Private company.
-
What is the current valuation of Reapplix?
The current valuation of Reapplix is
. -
What is Reapplix’s current revenue?
The current revenue for Reapplix is
. -
How much funding has Reapplix raised over time?
Reapplix has raised $48M.
-
Who are Reapplix’s investors?
Lauxera Capital Partners, MK Ventures, and North East Health Care are 5 of 10 investors who have invested in Reapplix.
, , -
Who are Reapplix’s competitors?
NOVADIP, Podimetrics, Amnio Technology, Mölnlycke Health Care, and Globus Medical are some of the 6 competitors of Reapplix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »